Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

(2020) Laure Gossec et al.   ANNALS OF THE RHEUMATIC DISEASES

Screening for psoriatic arthritis: targeting phenotypes may improve case detection

(2019) Rafic Baddoura et al.   JOINT BONE SPINE

Axial psoriatic arthritis: the impact of underdiagnosed disease on outcomes in real life

(2018) Sibel Zehra Aydin et al.   CLINICAL RHEUMATOLOGY

Influence of Axial Involvement on Clinical Characteristics of Psoriatic Arthritis: Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry

(2018) Philip J. Mease et al.   JOURNAL OF RHEUMATOLOGY

Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison

(2018) Joy Feld et al.   Nature Reviews Rheumatology

New GRAPPA and EULAR recommendations for the management of psoriatic arthritis

(2017) Laura C. Coates et al.   RHEUMATOLOGY

Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis

(2016) Deepak R Jadon et al.   ANNALS OF THE RHEUMATIC DISEASES

Imaging Scoring Methods in Axial Spondyloarthritis

(2016) Xenofon Baraliakos et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

(2015) Dominique Baeten et al.   NEW ENGLAND JOURNAL OF MEDICINE

Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis

(2015) Philip J. Mease et al.   NEW ENGLAND JOURNAL OF MEDICINE

The degree of spinal inflammation is similar in patients with axial spondyloarthritis who report high or low levels of disease activity: a cohort study

(2012) U Kiltz et al.   ANNALS OF THE RHEUMATIC DISEASES

MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor

(2012) Pedro Machado et al.   ANNALS OF THE RHEUMATIC DISEASES

Spondyloarthritis

(2011) Maxime Dougados et al.   LANCET

Risk Factors for Axial Inflammatory Arthritis in Patients with Psoriatic Arthritis

(2010) V. CHANDRAN et al.   JOURNAL OF RHEUMATOLOGY

Validity of the bath ankylosing spondylitis disease activity index for the evaluation of disease activity in axial psoriatic arthritis

(2009) José Luis Fernández-Sueiro et al.   ARTHRITIS CARE & RESEARCH